Related Experiment Video
Updated: Jul 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Effects of therapy with diet and simvastatin on atherosclerosis in hypercholesterolemic patients
C W Barlow1, B M Friedman, D P Myburgh
1Department of Cardiology, University of the Witwatersrand, Johannesburg, South Africa.
Insights
Cholesterol reduction using diet and simvastatin therapy stabilized coronary artery lesions in most patients. This cholesterol-lowering regimen showed potential for managing atherosclerosis progression.
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Background:
- Atherosclerotic coronary artery disease is a leading cause of mortality.
- High cholesterol levels, particularly LDL cholesterol, are a major risk factor for atherosclerosis.
- Statins, such as simvastatin, are effective in lowering cholesterol.
Purpose of the Study:
- To evaluate the impact of cholesterol reduction on coronary artery lesions.
- To assess the efficacy of a non-atherogenic diet combined with simvastatin therapy.
- To determine if lipid-lowering can alter the progression of coronary atherosclerosis.
Main Methods:
- Fifteen subjects with significant coronary artery narrowing and high cholesterol (>278 mg/dl) were enrolled.
- Participants received a non-atherogenic diet and simvastatin for approximately 20 months.
- Coronary arteriography was performed before and after treatment to assess lesion status.
Main Results:
- Therapy resulted in a 42% reduction in total cholesterol and a 52% reduction in LDL cholesterol.
- The HDL/LDL cholesterol ratio increased by 87% (p < 0.01).
- Coronary lesion status improved in 13% of patients, deteriorated in 7%, and remained unchanged in 80%.
Conclusions:
- Cholesterol-lowering therapy with diet and simvastatin may stabilize coronary atherosclerosis.
- This regimen demonstrates potential in managing the progression of atherosclerotic lesions.
- Further research is warranted to explore the long-term effects and broader applicability.
Abstract:
We evaluated the effect of cholesterol reduction on atherosclerotic coronary artery lesions using diet and simvastatin, a potent HMG CoA reductase inhibitor. Fifteen subjects aged 28-69 years (mean 44), each of whom demonstrated significant (greater than 50%) narrowing of a coronary artery and a baseline cholesterol level greater than 278 mg/dl, were studied. Coronary arteriography was performed prior to and after 20 +/- 2.5 months of therapy. A 42% reduction in total serum cholesterol, a 52% reduction in LDL cholesterol, and an 87% increase in the HDL/LDL cholesterol ratio (p less than 0.01) were achieved. Pretreatment and posttreatment angiograms were reviewed by three experienced angiographers with temporal order masked. Improvement in the overall status of coronary atherosclerotic lesions was demonstrated in two patients (13%), while deterioration occurred in one patient (7%). No overall change was found in the remaining 12 patients (80%). We conclude that a cholesterol-lowering regimen using a nonatherogenic diet and simvastatin therapy may at least stabilize coronary atherosclerosis.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management

